Literature DB >> 1402307

Induction chemotherapy with carboplatin and 5-fluorouracil in combination with radiotherapy in loco-regionally advanced epidermoid carcinoma of the anus--preliminary results.

C Svensson1, M Kaigas, S Goldman.   

Abstract

During the last decade conservative treatment of anal carcinoma based on radiotherapy has gained popularity. Radiotherapy is often combined with concurrent chemotherapy although no firm evidence exists that such combinations are more effective than radiotherapy alone. Treatment results with respect to anal sphincter function are generally better for small tumors. In an effort to improve the treatment results for locally advanced epidermoid anal carcinoma, a selection of patients with such tumors has been treated with induction chemotherapy comprising two or three courses of a combination of carboplatin 300-350 mg/m2 i.v. and 5-fluorouracil 1,000 mg/(m2 x d) x 5 d prior to radiotherapy. Six female patients aged 37 to 74 have completed the regimen. All had complete tumor regressions at conclusion of radiotherapy. No recurrence has yet occurred but the follow-up period is still short (8-21 months). No interruption of chemotherapy due to toxic side effects was necessary and no severe toxicity registered. Further study is needed to evaluate the efficacy and toxicity of the regimen, but these early findings are promising.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402307     DOI: 10.1007/bf00360350

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  14 in total

Review 1.  Preservation of function in the treatment of cancer of the anus.

Authors:  N D Nigro; V K Vaitkeviceus; A M Herskovic
Journal:  Important Adv Oncol       Date:  1989

2.  A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.

Authors:  V Grégoire; M Beauduin; Y Humblet; M Hamoir; J Longueville; F Majois; F M Remacle; F Rousseau; E Salamon; A Wambersie
Journal:  J Clin Oncol       Date:  1991-08       Impact factor: 44.544

3.  Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314.

Authors:  B Sischy; R L Doggett; J M Krall; D G Taylor; W T Sause; J A Lipsett; H G Seydel
Journal:  J Natl Cancer Inst       Date:  1989-06-07       Impact factor: 13.506

4.  Epidermoid carcinoma of the anal canal. A series of 276 cases.

Authors:  J Papillon; J F Montbarbon
Journal:  Dis Colon Rectum       Date:  1987-05       Impact factor: 4.585

5.  Radiation therapy of anal carcinoma.

Authors:  B Glimelius; S Graffman; L Påhlman; E Wilander
Journal:  Acta Radiol Oncol       Date:  1983

Review 6.  Current management of epidermoid carcinoma of the anal canal.

Authors:  B J Cummings
Journal:  Gastroenterol Clin North Am       Date:  1987-03       Impact factor: 3.806

7.  Squamous cell carcinoma of the anal canal: treatment by external beam irradiation.

Authors:  F Eschwege; P Lasser; A Chavy; P Wibault; J Kac; P Rougier; C Bognel
Journal:  Radiother Oncol       Date:  1985-02       Impact factor: 6.280

8.  Radiotherapy of epidermoid anal canal cancer.

Authors:  W Dobrowsky
Journal:  Br J Radiol       Date:  1989-01       Impact factor: 3.039

Review 9.  Combined modality treatment with radiotherapy and chemotherapy.

Authors:  I F Tannock
Journal:  Radiother Oncol       Date:  1989-10       Impact factor: 6.280

10.  Transanorectal ultrasonography in the staging of anal epidermoid carcinoma.

Authors:  S Goldman; U Norming; C Svensson; B Glimelius
Journal:  Int J Colorectal Dis       Date:  1991-08       Impact factor: 2.571

View more
  2 in total

1.  Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma.

Authors:  S Goldman; C Svensson; M Brönnergård; B Glimelius; G Wallin
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

2.  Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging.

Authors:  S D Otto; L Lee; H J Buhr; B Frericks; S Höcht; A J Kroesen
Journal:  J Gastrointest Surg       Date:  2009-04-14       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.